Second Russian virus vaccine passes early trials: Report

Russia's Vektor - a top-secret state virology research centre in Siberia - said that early-stage trials were successful for its own experimental vaccine, named EpiVacCorona. "The first two phases of clinical trials demonstrated the effectiveness and safety of the EpiVacCorona vaccine," Vektor's press department told the Interfax news agency.